Publications by authors named "Shu-Guang Piao"
Objective: To summarize and analyze the experience in the diagnosis and treatment of sexual activity-related hematuria.
Methods: A retrospective analysis was conducted on 12 cases of sexual activity-related hematuria treated in Changhai Hospital from October 2015 to April 2019. The patients ranged in age between 31 and 59 years, with a disease course of 2 weeks to 25 years, 6 complaining of urethral bleeding at penile erection and another 6 hematuria immediately after ejaculation, including 2 accompanied by hemospermia.
Article Synopsis
- The study examines the effectiveness of transurethral seminal vesiculoscopy (TSV) in treating recurrent hemospermia, documenting its application on 419 patients at Shanghai Changhai Hospital from 2007 to 2015.
- TSV was successful in 90.9% of cases, with 85% of patients reporting improvement or resolution of hemospermia three months post-surgery.
- Common intraoperative findings included bleeding and lesions, and the study categorizes the endoscopic appearance of the ejaculatory duct orifice into four distinct types, highlighting the need for further research to confirm these results.
Objective: To investigate the treatment of azoospermia induced by iatrogenic injury to the bilateral vas deferens.
Methods: We retrospectively analyzed 11 cases of azoospermia caused by iatrogenic injury to bilateral vas deferens. The patients were aged 20－33 years, all diagnosed with azoospermia preoperatively and none with a history of pelvic operation.
Objective: To investigate the feasibility and effect of transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory or recurrent hemospermia.
Methods: We retrospectively analyzed 162 cases of refractory or recurrent hemospermia examined and treated by transurethral seminal vesiculoscopy. The patients ranged in age from 19 to 76 years and had a hemospermia history of 3 months to 11 years, admitted due to poor therapeutic results or recurrence after 4 weeks of antibiotic medication.
Objective: Erectile dysfunction (ED) is now recognized as a comorbid condition, especially in men with cardiovascular disease or diabetes mellitus. This randomized controlled trial was to examine the effect of long-term small-dose tadalafil in the treatment of ED.
Methods: A total of 98 men older than 18 years with at least a 6-month ED history were enlisted and divided into two groups to receive once-daily treatment with tadalafil at 5 mg (n = 60) and 20 mg (n = 38), respectively, for 12 months.